Phenolic Phytochemical Scaffolds for Bone Metastasis Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for bone metastasis in cancers like prostate and breast cancer are ineffective and often have detrimental side effects on healthy bone tissue, with no cure available for bone metastasis, and existing therapies fail to address the mechanisms of metastasis effectively.
Innovation Solution
The use of phenolic phytochemicals from oregano, cranberry, and Rhodiola, incorporated into compositions with polymers and clays to form scaffolds, which are administered to induce apoptosis in bone metastatic cancer cells without harming healthy bone cells, utilizing a bioreactor for delivery and a bone mimetic scaffold for evaluation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional drugs are used to treat bone metastasis, then cancer cell growth is inhibited, but healthy bone tissue is damaged
Solution Approach 1:
The scaffold provides a localized delivery system that concentrates the phenolic phytochemical composition specifically at the bone metastasis site. The porous scaffold structure allows the composition to be delivered directly to cancer cells while minimizing exposure to healthy bone tissue, thereby treating the disease locally without systemic damage to healthy tissues.
Solution Approach 2:
The phenolic phytochemical composition acts as an intermediary substance that selectively targets cancer cells through the scaffold. The composition includes compounds from natural sources that mediate between the treatment goal (killing cancer cells) and the protection of healthy tissue, providing selective cytotoxicity against metastatic cells while sparing healthy bone cells.
2Reliability
If existing therapies are applied to treat bone metastasis, then tumor progression is slowed, but side effects increase
Solution Approach 1:
The invention extracts and utilizes specific phenolic phytochemicals from natural sources (oregano, cranberry, Rhodiola) that have selective anti-cancer properties. By taking out these specific bioactive compounds and delivering them through the scaffold, the therapy achieves metastasis control while avoiding the broad-spectrum toxicity and severe side effects associated with conventional chemotherapeutic agents.
Solution Approach 2:
The treatment changes the chemical parameters by using natural phenolic compounds instead of synthetic chemotherapeutics. This parameter change in the therapeutic agent results in different toxicity profiles - the natural phenolic compounds provide effective anti-metastatic activity with reduced side effects compared to conventional drugs.
3Ease of operation
If current treatments are used for bone metastasis, then palliative care is provided, but cure is not achieved
Solution Approach 1:
The scaffold delivers the phenolic phytochemical composition in advance to the bone metastasis site, preventing further cancer cell proliferation and colonization. By providing preliminary localized treatment at the metastatic site, the therapy aims to eliminate cancer cells before they can establish extensive secondary tumors, potentially achieving cure rather than just palliative care.
Data Source
AI summary
Compositions comprising phenolic phytochemicals of oregano, cranberry, or Rhodiola are provided. Compositions comprising a polymer, clay, and the phenolic phytochemicals are also provided. Methods of using the phenolic phytochemical compositions to treat a subject with bone metastasis are also provided, particularly methods of treating bone metastasis from breast or prostate cancer.